ArticleWorld journal of nephrology2024

Outcomes of a 12-month course of early and late rituximab BCD020 biosimilar administration in juvenile systemic lupus erythematosus: A retrospective study.

Elvira Kalashnikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.